Abscesshttps://en.wikipedia.org/wiki/Abscess
Abscess bụ nchịkọta pus nke wulitere n’ime akpụkpọ ahụ. Ihe ịrịba ama na mgbaàmà nke abscesses gụnyere ọbara, mgbu, ikpo ọkụ, na ọzịza. Ọzịza ahụ nwere ike ịdị jupụta mmiri mgbe a pịa ya. Ebe a na-acha uhie uhie na-adịkarị karịa ebe ọzịza.

Ihe na-ebutekarị ha bụ ọrịa nje. Nje bacteria na-emekarị bụ Staphylococcus aureus na-eguzogide methicillin. A na-eme nchọpụta ọzịza akpụkpọ ahụ dabere n'ụdị ya ma kwadoro ya site n'ịmeghe ya. Ihe onyonyo ultrasound nwere ike ịba uru n'ọnọdụ ebe nchọpụta ahụ edoghị anya. Na abscesses siri ike, computerized tomography (CT) nwere ike dị mkpa ịchọ omimi ọrịa.

Ọgwụgwọ mbụ maka ọtụtụ abscesses bụ imeghe ya ma wepụ pus, mgbe a na-eji ọgwụ nje. Iji agịga na-amịpụta ọtụ adịghị ezuru.

Ọzịza na-eme n’ahụkarị ma bụrụ nke a na-ahụ n’afọ ndị na-adịbeghị anya. Ihe ize ndụ gụnyere iji ọgwụ na eriri afọ, yana ọnụego ruru 65 % n’etiti ndị ọrụ. Na 2005, United States, nde mmadụ 3.2 gara ngalaba mberede maka abscesses. N’Australia, ihe dị ka mmadụ 13,000 nọ n'ụlọ ọgwụ na 2008 nwere ọnọdụ ahụ.

○ Ọgwụgwọ
Ịgwọ abscesses na ọgwụ ndị a na-ere ahịa na-esi ike n’ọtụtụ ọnọdụ. Ọ bụrụ na mgbaàmà dị ka ahụ ọkụ na oyi apụta n’ahụ niile, biko kpọtụrụ dọkịta ozugbo.

☆ AI Dermatology — Free Service
Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
  • inflamed epidermal cyst. A na-ahụ ntụpọ ojii na cyst dị n'okpuru akpụkpọ.
  • N'okwu a gbasara ọzịza ntì, a ga-atụlekwa ohere nke cyst epidermal.
  • Ụdị dị njọ nke abscess nwere ike ịhapụ ọnya. Obere erythema gburugburu ọnya na-egosi na ọrịa ahụ nọ n'ọnọdụ mkpebi.
  • Abscess ― ụbọchị ise ka mgbawa na mmiri gachara.
  • Ntụpọ ojii dị n'akụkụ elu nke etutu ahụ na-egosi epidermal cyst.
References Current Treatment Options for Acute Skin and Skin-structure Infections 30957166 
NIH
Ọtụtụ ndị mmadụ na-aga ụlọ ọgwụ mberede maka ọrịa anụ ahụ nke nje bacteria kpatara. Staphylococcus aureus bụ nje bụ isi na-akpata ọrịa ndị a, ọ na-esikarị ike ịgwọ ya n’ihi na community‑associated methicillin‑resistant Staphylococcus aureus (MRSA) pụtara.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
 Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus 32257966 
NIH
Enwere ike ịkewa Staphylococcus aureus n'ime ụzọ abụọ dabere na nzaghachi ha na ọgwụ nje: methicillin-sensitive Staphylococcus aureus (MSSA) na methicillin-resistant Staphylococcus aureus (MRSA). N'ime iri afọ ole na ole gara aga, n'ihi mmepe nke nje bacteria na iji ọgwụ nje eme ihe n'ụzọ na-apụtaghị ihe, nguzogide S. aureus na ọgwụ ndị a na-arị elu, nke na-ebute mmụba zuru ụwa ọnụ nke ọrịa MRSA.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
 Treatment of severe skin and soft tissue infections: a review 29278528 
NIH
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.